At the 10th East China OB-GYN Academic Conference, the SHURUI® single-port robotic system emerged as a leading innovation in minimally invasive surgery. Endorsed by Prof. Jinghe Lang and Prof. Zijiang Chen—both esteemed academicians of the Chinese Academy of Engineering—the system was praised for enhancing surgical precision and accessibility.
Powered by proprietary snake-arm technology, the SHURUI® system enables comprehensive access via a single incision or natural orifice, delivering outstanding outcomes in complex surgeries such as endometrial and cervical cancer. With over 1,000 successful cases across top-tier hospitals, its clinical reach now extends across OB-GYN, general, thoracic, pediatric, and ENT specialties.
From scar-free vNOTES to 5G-enabled remote surgery and AI-powered decision support, Surgerii Robotics is redefining the standard of ultra-minimally invasive care. By broadening indications and minimizing trauma, the company remains committed to making robotic surgery more accessible, more precise, and more patient-centered—both in China and around the world.
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.